Drawing for ADNIL

USPTO serial 88445519

ADNIL

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
BLANDU, FLORENTINA
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADNIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kurt D. Olender

KURT D. OLENDER OLENDERFELDMAN LLP422 MORRIS AVESUMMIT, NJ 07901UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplementsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2019MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Nov 1, 2019ABN5ABANDONMENT - AFTER PUBLICATION—
Oct 25, 2019EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Sep 4, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 6, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2019DOCKASSIGNED TO EXAMINER—
Jun 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 28, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance